Trial Profile
A pilot study to evaluate the efficacy of Omalizumab in patients with nasal polyposis and atopic asthma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Mar 2016
Price :
$35
*
At a glance
- Drugs Omalizumab (Primary)
- Indications Asthma; Nasal polyps
- Focus Therapeutic Use
- 16 Mar 2016 Trial focus and location assumed.
- 16 Mar 2016 New trial record